ANDA 40207, held by Duramed Pharms Barr. Prochlorperazine Maleate.
As of Nov 16, 2026, ANDA 40207 (Prochlorperazine Maleate), held by Duramed Pharms Barr, was first approved by FDA on May 1, 1997, with 5 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| May 1, 1997 | Original application | Approved |
| Prochlorperazine MaleateEQ 5MG BASE · tablet;oral | Prochlorperazine Maleate | Discontinued |
| Prochlorperazine MaleateEQ 10MG BASE · tablet;oral | Prochlorperazine Maleate | Discontinued |
| Dec 12, 2002 | Supplement 5Labeling | Approved | None posted |
| May 8, 2002 | Supplement 2Manufacturing | Approved | None posted |
| May 8, 2002 | Supplement 3Manufacturing | Approved | None posted |
| May 8, 2002 | Supplement 4Manufacturing | Approved | None posted |
| Oct 20, 1998 | Supplement 1Manufacturing | Approved | None posted |
| May 1, 1997 | Original application | Approved |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters